HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Catalyst Capital Advisors LLC

by · The Cerbat Gem

Catalyst Capital Advisors LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,166 shares of the company’s stock after selling 198 shares during the period. Catalyst Capital Advisors LLC’s holdings in HCA Healthcare were worth $1,094,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Congress Wealth Management LLC DE grew its holdings in HCA Healthcare by 3.4% during the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after acquiring an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its stake in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after purchasing an additional 35 shares in the last quarter. Perigon Wealth Management LLC raised its stake in HCA Healthcare by 2.3% during the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company’s stock valued at $621,000 after buying an additional 40 shares in the last quarter. Whittier Trust Co. grew its position in shares of HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock worth $359,000 after acquiring an additional 41 shares in the last quarter. Finally, Barden Capital Management Inc. lifted its stake in HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company’s stock worth $1,009,000 after purchasing an additional 41 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA opened at $372.84 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $89.69 billion, a P/E ratio of 16.58, a PEG ratio of 1.31 and a beta of 1.47. The stock has a fifty day moving average of $370.64 and a 200-day moving average of $338.65.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analysts’ expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.36 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare’s payout ratio is 12.81%.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently issued reports on HCA. Guggenheim began coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating on the stock. Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Robert W. Baird reiterated a “neutral” rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an “equal weight” rating in a research note on Monday, June 9th. Finally, Barclays set a $416.00 target price on shares of HCA Healthcare and gave the stock an “overweight” rating in a report on Monday, June 2nd. Eight investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $395.71.

Read Our Latest Analysis on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More